EP Patent

EP1188443A1 — Improved protocol for paracentesis

Assigned to Institut National de la Sante et de la Recherche Medicale INSERM · Expires 2002-03-20 · 24y expired

What this patent protects

The present invention is related to the novel use of terlipressin or analogs thereof in an improved method for the control of hypotension following paracentesis, particularly in cases of cirrhosis of the liver.

USPTO Abstract

The present invention is related to the novel use of terlipressin or analogs thereof in an improved method for the control of hypotension following paracentesis, particularly in cases of cirrhosis of the liver.

Drugs covered by this patent

Patent Metadata

Patent number
EP1188443A1
Jurisdiction
EP
Classification
—
Expires
2002-03-20
Drug substance claim
No
Drug product claim
No
Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.